Telix Pharmaceuticals Limited to acquire ARTMS Inc. and its Advanced Isotope Production Platform
Acquiring Company
Telix Pharmaceuticals Limited
Acquired Company
ARTMS
Melbourne
BurnabyBiotechnologyManufacturingBiotechnologyMedical DeviceDescription
Telix Pharmaceuticals Limited has announced an agreement to acquire ARTMS Inc., a venture-backed company known for its advanced cyclotron-based isotope production platform. This strategic acquisition is expected to enhance Telix’s vertical integration of supply chain and manufacturing, providing a greater level of control and security over the Company’s diagnostic isotopes. The acquisition also aims to facilitate the expansion of ARTMS’ R&D and production capabilities to support in-house and customer needs.
Quick answer
Telix Pharmaceuticals Limited is acquiring ARTMS, announced March 4, 2024. Telix Pharmaceuticals Limited is based in Melbourne, Victoria, Australia.
- How much did Telix Pharmaceuticals Limited pay for ARTMS?
- The deal value was not disclosed.
- What does Telix Pharmaceuticals Limited do?
- Telix Pharmaceuticals Limited (ASX: TLX) is a leading pharmaceutical company specializing in advanced diagnostic and therapeutic radiopharmaceuticals.
- Where are Telix Pharmaceuticals Limited and ARTMS based?
- Telix Pharmaceuticals Limited is based in Melbourne, Victoria, Australia. ARTMS is based in Burnaby, British Columbia, Canada.
- Who are the decision-makers at Telix Pharmaceuticals Limited?
- Fundz holds 1 contact at Telix Pharmaceuticals Limited. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical Device and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Wytech Industries and Mountain Manufacturing Technologies acquire Silvertip & Associates to strengthen precision grinding capabilities (April 3, 2024)
- ARTMS Inc. completes acquisition of Telix Pharmaceuticals Limited to strengthen medical isotope production (April 12, 2024)
- CoreRx, Inc. completes acquisition of Societal CDMO, Inc. to enhance drug formulation and manufacturing capabilities (April 8, 2024)
- Shimadzu Medical Systems USA completes acquisition of California X-ray Imaging Services, Inc. to strengthen Healthcare Business (April 6, 2024)
- Johnson & Johnson (J&J) completes $12.5 Billion Acquisition of Shockwave Medical to Strengthen Cardiac Health Solutions, $13B (April 5, 2024)
- Henry Schein completes acquisition of Majority Interest of TriMed, Inc. to strengthen orthopedic solutions (April 4, 2024)
Who to call at Telix Pharmaceuticals Limited, and when
When Telix Pharmaceuticals Limited changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Telix Pharmaceuticals Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Telix Pharmaceuticals Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Telix Pharmaceuticals Limited. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Telix Pharmaceuticals Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired ARTMS?
ARTMS was acquired by Telix Pharmaceuticals Limited, based in Melbourne. The deal was reported on March 4, 2024. Telix Pharmaceuticals Limited (ASX: TLX) is a leading pharmaceutical company specializing in advanced diagnostic and therapeutic radiopharmaceuticals. Telix Pharmaceuticals Limited is publicly traded (TLX) and operates in Biotechnology.
When did Telix Pharmaceuticals Limited acquire ARTMS?
Telix Pharmaceuticals Limited's acquisition of ARTMS was reported on March 4, 2024. Telix Pharmaceuticals Limited has announced an agreement to acquire ARTMS Inc., a venture-backed company known for its advanced cyclotron-based isotope production platform. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does ARTMS do?
ARTMS Inc. is a privately held, venture-backed company based in Burnaby, BC, Canada. The company specializes in the physics, chemistry, and materials science of cyclotron-produced radionuclides. It is privately held, operating in Manufacturing, and is based in Burnaby.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.